Publications by authors named "Roberto Bugarini"

Claim this Profile
I
Immunogenicity and safety of self-amplifying mRNA COVID-19 vaccine (ARCT-2303), with or without co-administration of seasonal inactivated influenza vaccine in adults: a phase 3, randomised, controlled, observer-blind, multicentre study.
Michelle L Giles, Charissa Tabora, Carmen Baccarini, Leonela Barrientos, Javier Cespedes Vargas, Roberto Bugarini

EClinicalMedicine· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized trial comparing safety, immunogenicity and efficacy of self-amplifying mRNA and adenovirus-vector COVID-19 vaccines.
Nhan Thi Ho, Steve G Hughes, Rose Sekulovich, Van Thanh Ta, Thuong Vu Nguyen, Roberto Bugarini

NPJ Vaccines· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early thymus and activation-regulated chemokine (TARC) reduction and response following panobinostat treatment in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplant.
Simon J Harrison, Andy K Hsu, Paul Neeson, Anas Younes, Anna Sureda, Roberto Bugarini

Leuk Lymphoma· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between quantitative GRB7 RNA expression and recurrence after adjuvant anthracycline chemotherapy in triple-negative breast cancer.
Joseph A Sparano, Lori J Goldstein, Barrett H Childs, Steven Shak, Diana Brassard, Roberto Bugarini

Clin Cancer Res· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physician survey of the effect of the 21-gene recurrence score assay results on treatment recommendations for patients with lymph node-positive, estrogen receptor-positive breast cancer.
Ruth Oratz, Benjamin Kim, Calvin Chao, Stanley Skrzypczak, Caron Ory, Roberto Bugarini

J Oncol Pract· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human immunodeficiency virus protease inhibitors reduce the growth of human tumors via a proteasome-independent block of angiogenesis and matrix metalloproteinases.
Elena Toschi, Cecilia Sgadari, Laura Malavasi, Ilaria Bacigalupo, Chiara Chiozzini, Roberto Bugarini

Int J Cancer· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study.
Mitch Dowsett, Jack Cuzick, Christopher Wale, John Forbes, Elizabeth A Mallon, Roberto Bugarini

J Clin Oncol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial.
Kathy S Albain, William E Barlow, Steven Shak, Gabriel N Hortobagyi, Robert B Livingston, Roberto Bugarini

Lancet Oncol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer.
Joseph A Sparano, Lori J Goldstein, Barrett H Childs, Steven Shak, Diana Brassard, Roberto Bugarini

Clin Cancer Res· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel mammalian cell-culture technique for consistent production of a well-tolerated and immunogenic trivalent subunit influenza vaccine.
Arvydas Ambrozaitis, Nicola Groth, Roberto Bugarini, Vittoria Sparacio, Audino Podda

Vaccine· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a novel influenza subunit vaccine produced in mammalian cell culture.
Agnieszka Szymczakiewicz-Multanowska, Nicola Groth, Roberto Bugarini, Maria Lattanzi, Daniela Casula

J Infect Dis· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunophenotype of HIV+ patients during CD4 cell-monitored treatment interruption: role of the IL-7/IL-7 receptor system.
Elisa Nemes, Enrico Lugli, Milena Nasi, Roberta Ferraresi, Marcello Pinti, Roberto Bugarini

AIDS· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccines with the MF59 adjuvant do not stimulate antibody responses against squalene.
Giuseppe Del Giudice, Elena Fragapane, Roberto Bugarini, Maninder Hora, Thomas Henriksson

Clin Vaccine Immunol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers.
Iain Stephenson, Maria C Zambon, Anna Rudin, Anthony Colegate, Audino Podda, Roberto Bugarini

J Virol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine.
Giuseppe Del Giudice, Anne Katrin Hilbert, Roberto Bugarini, Ada Minutello, Olga Popova

Vaccine· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic polymorphisms of Fas (CD95) and Fas ligand (CD178) influence the rise in CD4+ T cell count after antiretroviral therapy in drug-naïve HIV-positive patients.
Milena Nasi, Marcello Pinti, Roberto Bugarini, Leonarda Troiano, Enrico Lugli

Immunogenetics· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of treatment interruption monitored by CD4 cell count on mitochondrial DNA content in HIV-infected patients: a prospective study.
Cristina Mussini, Marcello Pinti, Roberto Bugarini, Vanni Borghi, Milena Nasi

AIDS· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy.
Iain Stephenson, Roberto Bugarini, Karl G Nicholson, Audino Podda, John M Wood

J Infect Dis· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly active antiretroviral therapy restores CD4+ Vbeta T-cell repertoire in patients with primary acute HIV infection but not in treatment-naive HIV+ patients with severe chronic infection.
Andrea Cossarizza, Fabrizio Poccia, Chiara Agrati, Gianpiero D'Offizi, Roberto Bugarini

J Acquir Immune Defic Syndr· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies.
Josè Ramòn Fiore, Barbara Suligoi, Annalisa Saracino, Mariantonietta Di Stefano, Roberto Bugarini

AIDS· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistently biased T-cell receptor repertoires in HIV-1-infected combination antiretroviral therapy-treated patients despite sustained suppression of viral replication.
Antonello Giovannetti, Marina Pierdominici, Marco Marziali, Francesca Mazzetta, Elisabetta Caprini, Roberto Bugarini

J Acquir Immune Defic Syndr· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody responses and HIV-1 viral load in HIV-1-seropositive subjects immunised with either the MF59-adjuvanted influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly active antiretroviral therapy.
Anna M Iorio, Daniela Francisci, Barbara Camilloni, Giuliano Stagni, Matteo De Martino, Roberto Bugarini

Vaccine· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infection with human herpesvirus-8 and its correlation with hepatitis B virus and hepatitis C virus markers among rural populations in Cambodia.
Loredana Sarmati, Massimo Andreoni, Barbara Suligoi, Roberto Bugarini, Ilaria Uccella

Am J Trop Med Hyg· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects.
Andrea De Luca, Roberto Bugarini, Alessandro Cozzi Lepri, Massimo Puoti, Enrico Girardi

Arch Intern Med· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinetics of CD4 cells after discontinuation of antiretroviral therapy in patients with virological failure and a CD4 cell count greater than 500 cells/microl.
Cristina Mussini, Roberto Bugarini, Carlo Federico Perno, Andrea Antinori, Vanni Borghi

AIDS· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis